Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 50% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 8 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors at 3 institutions in 2 countries.
Stacy C ParkDivision of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA sc5ma@hscmail.mcc.virginia.edu ajm5b@virginia.edu Jose.M.Munita@uth.tmc.edu.ORCID 0000-0002-1282-1389
Alexander M WailanDivision of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA.
Katie E BarryDivision of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA.
Kasi VegesanaHealth Information & Technology, University of Virginia Health System, Charlottesville, Virginia, USA.
Joanne CarrollClinical Microbiology Laboratory, Department of Pathology, University of Virginia Health System, Charlottesville, Virginia, USA.
Amy J MathersDivision of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA sc5ma@hscmail.mcc.virginia.edu ajm5b@virginia.edu Jose.M.Munita@uth.tmc.edu.ORCID 0000-0002-3533-6351
William R MillerCenter for Antimicrobial Resistance and Microbial Genomics, University of Texas Health Science Center, Houston, Texas, USA.
Jose M MunitaCenter for Antimicrobial Resistance and Microbial Genomics, University of Texas Health Science Center, Houston, Texas, USA sc5ma@hscmail.mcc.virginia.edu ajm5b@virginia.edu Jose.M.Munita@uth.tmc.edu.
University of Virginia Health System · USThe University of Texas Health Science Center at Houston · USUniversidad del Desarrollo · CL
Funding
INFECTIOUS DISEASES TRAINING PROGRAMT32AI007046 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Alison K Criss, William A Petri · 1985 to 2026
$15.3M
Role of YxdJK and DAK in the Enterococcal Envelope Stress ResponseK08AI135093 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MILLER, WILLIAM R · 2018 to 2022
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Managing All the Genotypic Knowledge: Approach to a Septic Patient Colonized by Different · full record | OpenQuestion